Introduction
============

The human genome is vulnerable to structural and chemical damage by various environmental and endogenous noxious stimuli. The integrity and stability of the genome are of paramount importance to its function as any alteration would result in malfunctioning of downstream pathways that could lead to disease or dysfunction. Alteration in the genome is a key step for cancer initiation and progression. Hence, it is not surprising that the human genome has more than 130 genes involved in recognizing and repairing DNA defects.[@b1-bic-6-2014-029] These genes control various DNA repair pathways involved in maintaining the genomic integrity. Polymorphisms in the genes coding for DNA repair proteins result in decreased removal of DNA damaged products, thereby, increasing the risk of developing cancer and age-related disorders.[@b2-bic-6-2014-029]

The nucleotide excision repair (NER) pathway is a complex and versatile DNA repair mechanism that rectifies various DNA defects caused by ultraviolet (UV)-induced lesions and bulky chemical adducts, and drug-induced DNA damage.[@b3-bic-6-2014-029] Various proteins are involved in the functioning of the NER pathway, and variants in the genes encoding for these proteins have been studied. Seven complementation groups (*XPA--XPG*) have been described, and they code for proteins involved in the NER pathway.[@b4-bic-6-2014-029]

The Xeroderma pigmentosum group A (*XPA*) gene codes for a protein that, along with the replication protein A (RPA) and Xeroderma pigmentosum group C (XPC), is involved in the initial sensing of the damage in the DNA strands,[@b5-bic-6-2014-029] and, hence, is called the *damage recognition factor*. A polymorphism in the *XPA*, the G23A polymorphism, is located in the 5′ untranslated region and is four nucleotides upstream of the start codon. Mutations in this region are known to cause low levels of protein expression because of the differential binding of the 40S ribosome to the promoter region.[@b6-bic-6-2014-029] The Xeroderma pigmentosum group D (*XPD*), also known as the Excision repair cross-complementing 2 (*ERCC2*), codes for a protein that forms three of the nine subunits that constitute the transcription factor IIH (TFIIH).[@b7-bic-6-2014-029] TFIIH is involved in the transcription of the DNA during the DNA repair process. Mutations in the *XPD* can diminish the activity of these proteins and result in an abnormal DNA repair process. A total of 17 single nucleotide polymorphisms (SNPs) of *XPD* have been described, of which the Lys751Gln (rs13181) results in an amino acid change and, consequently, can affect protein function.[@b8-bic-6-2014-029] The *XPG* gene codes for an endonuclease that helps in the nicking of damaged DNA fragments and plays a pivotal role in the NER pathway.[@b9-bic-6-2014-029] Two important SNPs in the *XPG* gene are the *XPG* His46His (rs1047768) and *XPG* Asp1104His (rs17655). Mutations of the genes encoding proteins in the NER pathway have been studied and found to be associated with various cancers.

The X-ray repair cross-complementing group 1 (*XRCC1*) gene codes for a scaffolding protein that plays a role in the base excision repair (BER) pathway. DNA repair is brought about by its complex interactions with DNA polymerase-β, poly (ADP-ribose) polymerase, and DNA ligase III.[@b10-bic-6-2014-029],[@b11-bic-6-2014-029] *XRCC1* is required for the efficient repair of single-strand breaks (SSBs).[@b12-bic-6-2014-029] SSBs occur in the cell because of the oxidative damage produced by the reactive oxygen species (ROS), because of the anomalous activity of certain enzymes involved in DNA replication, or during repair of DNA by other repair pathways.[@b13-bic-6-2014-029] Genetic alterations of the *XRCC1* may result in a dysfunctional protein with impaired repair capacity, thus, increasing risk of cancer in an individual. A common genetic variant of *XRCC1*, Arg399Gln, has been implicated in various cancers.[@b14-bic-6-2014-029]

Apart from conferring increased susceptibility to cancer risk, mutations in the DNA repair pathway also alter the sensitivity to cancer chemotherapy.[@b15-bic-6-2014-029] Platinum-based chemotherapeutic agents, which includes cisplatin, carboplatin, and oxaliplatin, are commonly used as first-line chemotherapeutic agents for many cancers. The platinum compounds form DNA adducts and cause cell death. Efficient NER of the DNA damage decreases the efficiency to cause tumor cell death and might result in resistance to these compounds, whereas a deficiency in the DNA repair will increase the efficiency.[@b16-bic-6-2014-029]

India is a country with a vast population derived from various ethnic groups. Hence, genetic differences are common among various groups within India, and the South Indian population represents a genetically distinct group.[@b17-bic-6-2014-029] Such genetic differences within populations can confound genotype--phenotype association studies and are the major reasons for the conflicting results. In this study, we aim to establish the normative frequency of five SNPs of genes involved in DNA repair pathways, viz, *XPA* G23A (rs1800975), *ERCC2/XPD* Lys751Gln (rs13181), *XPG* His46His (rs1047768), *XPG* Asp1104His (rs17655), and *XRCC1* Arg399Gln (rs25487) (details of the polymorphisms are shown in [Table 1](#t1-bic-6-2014-029){ref-type="table"}). We also aim to evaluate the similarity or dissimilarity between various HapMap populations such as CEU (Utah residents with Northern and Western European ancestry), HCB (Han Chinese in Beijing, China), JPT (Japanese in Tokyo, Japan), YRI (Yoruba in Ibadan, Nigeria), GIH (Gujarat Indians in Houston), and MEX (Mexican ancestry in Los Angeles, CA).

Methodology
===========

Study subjects
--------------

The study was carried out on 128 healthy individuals between 18 and 70 years of age. Unrelated individuals from the general population, residing in the Southern states of India (Tamil Nadu, Kerala, Karnataka, and Andhra Pradesh) for three consecutive generations and speaking a Dravidian language (Tamil, Malayalam, Kannada, and Telugu), were selected for the study. The study subjects comprised 73 males and 55 females, and the mean age (±SD) was 34.8 (±14.5) years. Ethical approval was obtained from the Institute Ethics Committee, JIPMER (Jawaharlal Institute of Postgraduate Medical Education and Research), Pondicherry, India. Written informed consent was obtained from all subjects participating in the study. The study was in compliance with the good clinical practice according to the principles of the Declaration of Helsinki.

DNA extraction
--------------

Approximately 5 mL of venous blood was collected from each study subject in tubes containing 100 μL of 10% ethylene diaminetetraacetic acid (EDTA). Genomic DNA was extracted using the standard phenol--chloroform extraction method.[@b18-bic-6-2014-029] The isolated DNA was stored at −20°C until genotyping.

Genotyping
----------

Five SNPs in DNA repair genes---*XPA* G23A (rs1800975), *ERCC2/XPD* Lys751Gln (rs13181), *XPG* His46His (rs1047768), *XPG* Asp1104His (rs17655), and *XRCC1* Arg399Gln (rs25487)---were genotyped by RT-PCR (Real time polymerase chain reaction) (Applied Biosystems 7300) using TaqMan SNP genotyping assay kits ([Table 1](#t1-bic-6-2014-029){ref-type="table"}). Genomic DNA was diluted to 50 ng/μL, and 2.5 μL was used for RT-PCR. In all, 5 μL of TaqMan Universal PCR master mix and 0.25 μL of TaqMan genotyping assay were added to the diluted DNA, and deionized water was added to make up the final volume to 10 μL. The thermocycler was set at 50°C for two minutes and at 95°C for 10 minutes to activate polymerase AmpliTaq Gold. In all, 40 cycles of denaturation (92°C for 15 seconds) and annealing-extension (60°C for 1 minute) were used to amplify the DNA sequence. Allelic discrimination was done by 7300 sequence detection software (SDS), version 1.4. The allelic discrimination plots of the five SNPs are shown in [Figures 1](#f1-bic-6-2014-029){ref-type="fig"}--[5](#f5-bic-6-2014-029){ref-type="fig"}. For quality control, 10% of the samples were reanalyzed, and the results were found to be 100% concordant.

Statistical analysis
--------------------

The genotype and allele frequencies were determined by direct gene count method. The genotype frequencies were tested for Hardy-Weinberg equilibrium using the chi-square (χ^2^) test by comparing the observed frequencies with the expected frequencies. Chi-square test was also used to assess the differences in allele frequencies between the study population and populations of different ethnicities. Statistical analysis was performed using GraphPad InStat 3.

Results
=======

The observed allele frequencies of all the five SNPs were in Hardy--Weinberg equilibrium. Gender-wise stratification of the genotype and allele frequencies of the five SNPs was done and is shown in [Table 2](#t2-bic-6-2014-029){ref-type="table"}. The allele frequencies did not differ significantly between males and females.

*XPA* G23A (rs1800975)
----------------------

The *XPA* G23A had G allele frequency of 50.8% and A allele frequency of 49.2%. The heterozygous genotype GA was seen in 42.2% while the homozygous genotypes GG and AA were seen in 29.7% and 28.1%, respectively ([Table 3](#t3-bic-6-2014-029){ref-type="table"}). The allele frequencies were significantly different from those observed among the CEU, YRI, and MEX. They were similar to the HCB, JPT, and GIH.

*ERCC2/XPD* Lys751Gln A\>C (rs13181)
------------------------------------

The observed genotype and allele frequencies of *ERCC2/XPD* Lys751Gln are shown in [Table 4](#t4-bic-6-2014-029){ref-type="table"}. The genotype frequencies of AA, AC, and CC were 43.0%, 41.4%, and 15.6%, respectively. The minor allele C had a frequency of 36.3%, highest among the populations compared. The allele frequencies observed in South Indians were significantly different from HCB, JPT, YRI, and MEX populations, while being similar to CEU and GIH. The C allele was as low as 7.6% in the JPT.

*XPG* His46His T\>C (rs1047768)
-------------------------------

The genotype and allele frequencies of *XPG* His46His are shown in [Table 5](#t5-bic-6-2014-029){ref-type="table"}. T allele and C allele had frequencies of 52.0% and 48.0%, respectively. The TT and CC genotypes were seen in 28.9% and 25.0%, respectively, while the heterozygous TC was present in 46.1%. The allele frequencies were found to be significantly different from all the populations compared.

*XPG* Asp1104His G\>C (rs17655)
-------------------------------

The genotype and allele frequencies of *XPG* Asp1104His are shown in [Table 6](#t6-bic-6-2014-029){ref-type="table"}. The GG and GC genotypes were seen in 59.4% and 35.1%, respectively, while the homozygous mutant CC was observed in 5.5%. The allele frequencies of G and C alleles were 77.0% and 23.0%, respectively. The allele frequencies of the South Indian population studied differed significantly from all the populations compared.

*XRCC1* Arg399Gln G\>A (rs25487)
--------------------------------

The genotype frequencies of GG, GA, and AA of *XRCC1* Arg399Gln were 46.9%, 38.3%, and 14.8%, respectively ([Table 7](#t7-bic-6-2014-029){ref-type="table"}). The G allele frequency was calculated to be 66.0%, and the A allele frequency was 34.0%. The allele frequencies were found to be statistically divergent from YRI. The minor allele frequency varied from 11.1% in YRI to 40.9% in GIH.

Discussion
==========

The aim of the present study was to investigate the frequency of genetic polymorphisms in the *XPA, XPD, XPG*, and *XRCC1* genes in a South Indian healthy population. We report the genotype and allele frequencies of five different polymorphisms in DNA repair genes.

In our study, the allele frequencies of *XPA* G23A showed a significant deviation from the CEU, YRI, and MEX. The presence of G allele has been shown to decrease the risk of lung cancer among non-Caucasians, while this effect was not seen in the Caucasians.[@b19-bic-6-2014-029] Further, ethnic specific differences were observed in its association with head and neck and colorectal cancers, a protective effect of the G allele being greater in the Asian population.[@b20-bic-6-2014-029] Moreover, *XPA* polymorphisms have a role as a predictive biomarker of response to platinum-based chemotherapy, especially in non-small-cell lung cancer.[@b21-bic-6-2014-029],[@b22-bic-6-2014-029]

The *ERCC2/XPD* Lys751Gln polymorphism frequencies showed a significant deviation from the populations of HCB, JPT, YRI, and MEX. The minor allele frequency was found to be similar to a study on the Northern Indian population by Gangwar et al[@b23-bic-6-2014-029] and on South Indians by Vettriselvi et al.[@b24-bic-6-2014-029] This polymorphism has been associated with an increased risk of cancers of the lung,[@b25-bic-6-2014-029] bladder,[@b26-bic-6-2014-029] prostate,[@b27-bic-6-2014-029] and brain.[@b28-bic-6-2014-029] A recent study also revealed that the *XPD* polymorphism can be useful as a biomarker for tamoxifen response in breast cancer patients.[@b29-bic-6-2014-029] Recently, we established the frequency distribution of another polymorphism *ERCC2/XPD* Asp312Asn and two important polymorphisms of the *ERCC1* in South Indian population.[@b30-bic-6-2014-029]

We report, to the best of our knowledge, for the first time in South Indian population, the allele and genotype frequencies of *XPG* His46His and Asp1104His. We observe the allele frequencies of both the SNPs to be completely deviant in the rest of the populations from the HapMap such as the CEU, HCB, JPT, and YRI. Heterozygous genotype of the *XPG* His46His was observed in a larger group of subjects similar to other populations, unlike the HCB or JPT. The present study population also had almost equal frequencies of both the alleles. Interestingly, the GG genotype of the *XPG* Asp1104His was higher in our population, quite contrary to the rest of the populations compared with. CC was the major genotype in CEU, while the heterogeneous genotype GC was major genotype in HCB, JPT, and YRI. Very few studies evaluating *XPG* gene polymorphisms are available from India, and a North Indian study reported the heterogeneous genotype to be the commonest genotype in the healthy population.[@b31-bic-6-2014-029] This probably suggests that inter-ethnic variations exist in the distribution of *XPG* gene polymorphisms. *XPG* His46His has been associated with colon[@b32-bic-6-2014-029] and prostate cancer.[@b31-bic-6-2014-029] It also has a role in predicting response to platinum-based chemotherapy.[@b33-bic-6-2014-029],[@b34-bic-6-2014-029] The Asp1104His, on the other hand, has been associated with an increased risk of cutaneous melanoma[@b35-bic-6-2014-029] and breast cancer.[@b36-bic-6-2014-029] Other studies show weak or no association with cancer.[@b37-bic-6-2014-029],[@b38-bic-6-2014-029]

The *XRCC1* Arg399Gln gene polymorphism frequency in South Indians was comparable to the populations such as CEU, HCB, JPT, GIH, and MEX. However, it showed a significant deviation from YRI. A study from the northern part of India of 150 healthy volunteers found the minor allele frequency to be 43%, higher than the present study population (34%).[@b39-bic-6-2014-029] A recent study from Northern India, evaluating the role of Arg399Gln in colorectal cancer, found a higher percentage of homozygous mutants than our study.[@b40-bic-6-2014-029] Arg399Gln has been found to be associated strongly with hepatocellular carcinoma in the Asian population and breast cancer in Indians.[@b41-bic-6-2014-029] Various studies have shown its association with the risk of lung cancer,[@b42-bic-6-2014-029],[@b43-bic-6-2014-029] glioma,[@b28-bic-6-2014-029],[@b44-bic-6-2014-029] endometrial carcinoma,[@b45-bic-6-2014-029] breast cancer,[@b46-bic-6-2014-029] etc.

We did not find a difference in the distribution of these polymorphisms between the genders, and the differential risk that these genotypes confer on males and females might be because of the dietary habits and interaction with other environmental factors as explained by Wang et al.[@b47-bic-6-2014-029]

To the best of our knowledge, this is the first study to establish the frequency distribution of *XPA* and *XPG* gene polymorphisms in South Indian population. To conclude, we report the frequency distribution of five SNPs in DNA repair pathways, and the present work forms the groundwork for cancer association studies and biomarker identification for treatment response and prognosis.
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###### 

Characteristic features, rs IDs, and assay IDs of the DNA repair gene polymorphisms studied.

  GENE          SNP           BASE PAIR CHANGE   GENE LOCATION   SNP LOCATION   rs ID       ASSAY ID
  ------------- ------------- ------------------ --------------- -------------- ----------- ---------------------
  *XPA*         G23A          G\>A               9q22.3          5′ UTR         rs1800975   C\_\_\_\_482935_1\_
  *ERCC2/XPD*   Lys751Gln     A\>C               19q13.3         Exon 23        rs13181     C\_\_\_3145033_10
  *XPG*         His46His      T\>C               13q33.1         Exon 2         rs1047768   C\_\_\_1891769_20
  *XPG*         Asp110 4His   G\>C               13q33.1         Exon 15        rs17655     C\_\_\_\_1891743_10
  *XRCC1*       Arg399Gln     G\>A               19q13.2         Exon 10        rs25487     C\_\_\_\_622564_10

**Abbreviations**: SNP, single nucleotide polymorphism; 5′ UTR, untranslated region; Lys, lysine; Gln, glutamine; His, histidine; Asp, aspartate; Arg, arginine.

###### 

Gender-wise genotype and allele frequency distribution of DNA repair gene polymorphisms in the study population.

  SNP             GENOTYPE FREQUENCY (%)            ALLELE FREQ UENCY (%)   *P* VALUE           
  --------------- ------------------------ -------- ----------------------- ----------- ------- --------
  **rs13181**     **AA**                   **AC**   **CC**                  **A**       **C**   0.1928
  Male (73)       39.7                     41.1     19.2                    60.3        39.7    
  Female (55)     47.3                     41.8     10.9                    68.2        31.8    
  **rs25487**     **GG**                   **GA**   **AA**                  **G**       **A**   0.8693
  Male (73)       46.6                     39.7     13.7                    66.4        33.6    
  Female (55)     47.3                     36.4     16.4                    65.5        34.5    
  **rs1800975**   **GG**                   **GA**   **AA**                  **G**       **A**   0.6387
  Male (73)       30.1                     43.8     26.0                    52.1        47.9    
  Female (55)     29.1                     40.0     30.9                    49.1        50.9    
  **rs1047768**   **TT**                   **TC**   **CC**                  **T**       **C**   0.6399
  Male (73)       30.1                     41.1     28.8                    50.7        49.3    
  Female (55)     27.3                     52.7     20.0                    53.6        46.4    
  **rs17655**     **GG**                   **GC**   **CC**                  **G**       **C**   0.2740
  Male (73)       63.0                     32.9     4.1                     79.5        20.5    
  Female (55)     54.5                     38.2     7.3                     73.6        26.4    

###### 

Comparison of the genotype and allele frequencies of *XPA* G23a polymorphism with HapMap populations.

  POPULATION           N     GENOTYPE FREQUENCY (%)   ALLELE FREQUENCY (%)   *P* VALUE                 
  -------------------- ----- ------------------------ ---------------------- ----------- ------ ------ ----------
  Present study (SI)   128   29.7                     42.2                   28.1        50.8   49.2   Ref.
  CEU                  226   37.2                     49.6                   13.3        61.9   38.1   0.0038
  HCB                  86    20.9                     60.5                   18.6        51.2   48.8   0.9383
  JPT                  168   29.8                     42.9                   27.4        51.2   48.8   0.9214
  YRI                  226   56.6                     40.7                   2.7         77.0   23.0   \<0.0001
  GIH                  176   30.7                     47.7                   21.6        54.5   45.5   0.3585
  MEX                  100   40.0                     42.0                   18.0        61.0   39.0   0.0294

**Abbreviations:** *N*, number of subjects; SI, South Indian; CEU, Utah residents with Northern and Western European ancestry; HCB, Han Chinese in Beijing, China; JPT, Japanese in Tokyo, Japan; YRI, Yoruba in Ibadan, Nigeria; GIH, Gujarat Indians in Houston, TX; and MEX, Mexican ancestry in Los Angeles, CA.

###### 

Comparison of the allele and genotype frequencies of *ERCC2/XPD* Lys751Gln (A\>C) polymorphism with HapMap populations.

  POPULATION           N     GENOTYPE FREQUENCY (%)   ALLELE FREQUENCY (%)   *P* VALUE                 
  -------------------- ----- ------------------------ ---------------------- ----------- ------ ------ ----------
  Present study (SI)   128   43.0                     41.4                   15.6        63.7   36.3   Ref.
  CEU                  226   40.7                     52.2                   7.1         66.8   33.2   0.3975
  HCB                  86    83.7                     16.3                   0.0         91.9   8.1    \<0.0001
  JPT                  172   86.0                     12.8                   1.2         92.4   7.6    \<0.0001
  YRI                  226   64.6                     33.6                   1.8         81.4   18.6   \<0.0001
  GIH                  176   39.8                     48.9                   11.4        64.2   35.8   0.8925
  MEX                  100   62.0                     34.0                   4.0         79.0   21.0   0.0004

**Abbreviations:** *N*, number of subjects; SI, South Indian; CEU, Utah residents with Northern and Western European ancestry; HCB, Han Chinese in Beijing, China; JPT, Japanese in Tokyo, Japan; YRI, Yoruba in Ibadan, Nigeria; GIH, Gujarat Indians in Houston, TX; and MEX, Mexican ancestry in Los Angeles, CA.

###### 

Comparison of the genotype and allele frequencies of *XPG* His46His (T\>C) polymorphism with HapMap populations.

  POPULATION           N     GENOTYPE FREQUENCY (%)   ALLELE FREQUENCY (%)   *P* VALUE                 
  -------------------- ----- ------------------------ ---------------------- ----------- ------ ------ ----------
  Present study (SI)   128   28.9                     46.1                   25.0        52.0   48.0   Ref.
  CEU                  226   17.7                     49.6                   32.7        42.5   57.5   0.0151
  HCB                  86    55.8                     34.9                   9.3         73.3   26.7   \<0.0001
  JPT                  172   68.6                     29.1                   2.3         83.1   16.9   \<0.0001
  YRI                  224   8.0                      42.0                   50.0        29.0   71.0   \<0.0001
  GIH                  176   38.6                     45.5                   15.9        61.4   38.6   0.0205
  MEX                  100   36.0                     52.0                   12.0        62.0   38.0   0.0318

**Abbreviations:** *N*, number of subjects; SI, South Indian; CEU, Utah residents with Northern and Western European ancestry; HCB, Han Chinese in Beijing, China; JPT, Japanese in Tokyo, Japan; YRI, Yoruba in Ibadan, Nigeria; GIH, Gujarat Indians in Houston, TX; and MEX, Mexican ancestry in Los Angeles, CA.

###### 

Comparison of the genotype and allele frequencies of *XPG* Asp1104His (G\>C) polymorphism with HapMap populations.

  POPULATION           N     GENOTYPE FREQUENCY (%)   ALLELE FREQUENCY (%)   *P* VALUE                 
  -------------------- ----- ------------------------ ---------------------- ----------- ------ ------ ----------
  Present study (SI)   128   59.4                     35.1                   5.5         77.0   23.0   Ref.
  CEU                  120   6.7                      40.0                   53.3        26.7   73.3   \<0.0001
  HCB                  90    15.6                     57.8                   26.7        44.4   55.6   \<0.0001
  JPT                  88    25.0                     54.5                   20.5        52.3   47.7   \<0.0001
  YRI                  120   28.3                     51.7                   20.0        54.2   45.8   \<0.0001

**Abbreviations:** *N*, number of subjects; SI, South Indian; CEU, Utah residents with Northern and Western European ancestry; HCB, Han Chinese in Beijing, China; JPT, Japanese in Tokyo, Japan; and YRI, Yoruba in Ibadan, Nigeria.

###### 

Comparison of the genotype and allele frequencies of *XRCC1* Arg399Gln (G\>A) polymorphism with HapMap populations.

  POPULATION           N     GENOTYPE FREQUENCY (%)   ALLELE FREQUENCY (%)   *P* VALUE                 
  -------------------- ----- ------------------------ ---------------------- ----------- ------ ------ ----------
  Present study (SI)   128   46.9                     38.3                   14.8        66.0   34.0   Ref.
  CEU                  224   38.4                     50.0                   11.6        63.4   36.6   0.4846
  HCB                  84    52.4                     40.5                   7.1         72.6   27.4   0.1518
  JPT                  172   52.3                     40.7                   7.0         72.7   27.3   0.0788
  YRI                  226   77.9                     22.1                   0           88.9   11.1   \<0.0001
  GIH                  176   34.1                     50.0                   15.9        59.1   40.9   0.0824
  MEX                  98    42.9                     49.0                   8.2         67.3   32.7   0.7662

**Abbreviations:** *N*, number of subjects; SI, South Indian; CEU, Utah residents with Northern and Western European ancestry; HCB, Han Chinese in Beijing, China; JPT, Japanese in Tokyo, Japan; YRI, Yoruba in Ibadan, Nigeria; GIH, Gujarat Indians in Houston, TX; and MEX, Mexican ancestry in Los Angeles, CA.
